| Sandoz Pharmaceuticals AG - Omnitrope 10 mg, Injektionslösung |
| 61306 | | 02 | | Omnitrope 10 mg | | Injektionslösung | | H01AC01 | | Somatropin | | 27.07.2010 | | |
|
| Composition |
| somatropinum ADNr 10.0 mg corresp. 30.0 U.I., dinatrii phosphas heptahydricus, natrii dihydrogenophosphas dihydricus, poloxamerum 188, phenolum, glycinum, acidum phosphoricum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium 0.51 mg. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Somatropinum Adnr | 10 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Somatropinum Adnr | 10 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acide Phosphorique | | | Disodium Phosphate Heptahydrate | | | Glycine | | | Sodium Dihydrogenophosphate Dihydrate | | | Sodium Hydroxide | | | Phenol | | | Poloxamer | 188 |
| |
|
|
